Aerie Pharmaceuticals.

PositionTRIANGLE

RESEARCH TRIANGLE PARK -- Aerie Pharmaceuticals, a biotechnology company spun off by Duke University, landed $21 million in first-round venture capital. Investors were led by San Francisco-based Alta Partners and Fort Worth, Texas-based Texas...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT